Key result
Higher pre-stroke fasting glucose variability is linked to ~56% greater post-stroke mortality in non-diabetic patients.
Why the study?
Does pre-stroke impaired fasting glucose and high fasting blood glucose variability increase post-stroke all-cause mortality in non-diabetic ischemic stroke patients?
Cohort (n=193,705)
Does pre-stroke impaired fasting glucose and high fasting blood glucose variability increase post-stroke all-cause mortality in non-diabetic ischemic stroke patients?
Answers are grounded in this paper and cite their sources.
In non-diabetic ischemic stroke patients, high pre-stroke fasting blood glucose variability is an independent predictor of post-stroke all-cause mortality, and its effect is synergistically amplified by impaired fasting glucose.
Introduction: The influence of pre-stroke long-term fasting blood glucose (FBG) and its variability on post-stroke all-cause mortality in ischemic stroke (IS) patients without diabetes remains unclear. This study aimed to investigate their independent and joint effects on all-cause mortality in this specific population. Methods: We included 193,705 non-diabetic IS patients from the Northwest China Real-world and Population-based Tianshan Cohort 2019 to 2023. Cox proportional hazards regression models assessed the associations of impaired fasting glucose (IFG; 6.1-6.9 mmol/L) and high FBG variability with post-stroke all-cause mortality risk. Additive and multiplicative interactions between the two exposures were evaluated using the delta method and likelihood ratio tests, respectively. Results: 14,481 patients (7.5%) died during a median follow-up of 0.87 years. IFG showed no significant association with mortality risk. Higher FBG variability (LogVIM Q5 vs Q1) significantly raised mortality risk (HR 1.56, 95% CI: 1.48-1.64; Ptrend < 0.001). A significant interaction between IFG and high FBG variability was observed on both additive (RERI 0.30 95% CI 0.13-0.49, P = 0.006) and multiplicative scales (HR 1.34, 95% CI 1.13-1.58; P = 0.001). Conclusions: Long-term pre-stroke FBG variability is an independent predictor of post-stroke all-cause mortality among non-diabetic IS patients, while IFG is not. However, IFG amplifies the effect of FBG variability. Their combination shows synergistic risk elevation.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) conducted a cohort in non-diabetic ischemic stroke (n=193,705). High fasting blood glucose variability vs. Low fasting blood glucose variability was evaluated on post-stroke all-cause mortality (HR 1.56, 95% CI 1.48-1.64, p=<0.001). Higher pre-stroke fasting blood glucose variability increased post-stroke all-cause mortality risk in non-diabetic ischemic stroke patients.
Synapse has enriched 10 related papers. Consider them for comparative context: